Loading…

Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests

Background: Bronchial provocation tests such as exercise, methacholine (MCH), and adenosine-5′-monophosphate (AMP) challenges are used extensively in the diagnosis of asthma. A study was undertaken to determine whether exhaled nitric oxide (eNO) can be used to diagnose asthma in patients with non-sp...

Full description

Saved in:
Bibliographic Details
Published in:Thorax 2005-05, Vol.60 (5), p.383-388
Main Authors: Berkman, N, Avital, A, Breuer, R, Bardach, E, Springer, C, Godfrey, S
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b522t-78b3b7778a1f31c9de0b1a20f9010c5e64cdd8bb1900ae1fde5c45120fd154e03
cites
container_end_page 388
container_issue 5
container_start_page 383
container_title Thorax
container_volume 60
creator Berkman, N
Avital, A
Breuer, R
Bardach, E
Springer, C
Godfrey, S
description Background: Bronchial provocation tests such as exercise, methacholine (MCH), and adenosine-5′-monophosphate (AMP) challenges are used extensively in the diagnosis of asthma. A study was undertaken to determine whether exhaled nitric oxide (eNO) can be used to diagnose asthma in patients with non-specific respiratory symptoms and to compare this test with conventional provocation tests. Methods: Patients with non-specific respiratory symptoms and normal spirometric parameters were included in the study. eNO was measured and exercise, MCH and AMP challenges performed in all subjects. Patients were defined as asthmatic based on clinical follow up 24 months after testing. Results: Forty patients were considered asthmatic and 45 were not. The area under receiver operating characteristic curves gave values of 0.896 for eNO, 0.781 for exercise, 0.924 for MCH, and 0.939 for AMP (p = 0.033, 0.575 and 0.085 for eNO v exercise, MCH and AMP respectively). From our data, a cut off value of NO >7 ppb at a flow rate of 250 ml/s best differentiates between asthmatics and non-asthmatics (sensitivity 82.5%, specificity 88.9%). Optimal cut off values for other tests were exercise: ΔFEV1 ⩾10% (sensitivity 57.9%, specificity 100%); PC20-MCH: ⩽3 mg/ml (sensitivity 87.5%, specificity 86.7%); and PC20-AMP: ⩽150 mg/ml (sensitivity 89.5%, specificity 95.6%). Conclusions: Measurement of eNO can be used as a safe, simple and rapid test for the diagnosis of asthma and is as good as bronchial provocation tests.
doi_str_mv 10.1136/thx.2004.031104
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1758892</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4026836941</sourcerecordid><originalsourceid>FETCH-LOGICAL-b522t-78b3b7778a1f31c9de0b1a20f9010c5e64cdd8bb1900ae1fde5c45120fd154e03</originalsourceid><addsrcrecordid>eNqFkc2LFDEUxIMo7rh69iYB0YPQs3n9kaQ9CDKsrrD4AepBhPA6nd7O2J2MSWYd_3uzzrCrXjy9Q_1eUUUR8hDYEqDiJ2ncLUvG6iWrAFh9iyyg5rKoypbfJosssIJXgh-RezGuGWMSQNwlR9BIzgRUC_L1dDfiZHrqbApWU7-zvaHW0TQa2lu8cD7aSP1AMaZxxudU-3mDwUbv6A-bRtoF7_RocaKb4C-9xmSzlExM8T65M-AUzYPDPSafXp1-XJ0V5-9ev1m9PC-6pixTIWRXdUIIiTBUoNvesA6wZEPLgOnG8Fr3vew6aBlDA0NvGl03kIEemtqw6pi82Ptutt1sem1cCjipTbAzhp_Ko1V_K86O6sJfKhCNlG2ZDZ4eDIL_vs3R1WyjNtOEzvhtVFyItpQtz-Djf8C13waXy2UvCYJDWYpMnewpHXyMwQzXUYCpq91U3k1d7ab2u-WPR382uOEPQ2XgyQHAqHEaAjpt4w3HZc3Fb6Niz9mYzO5ax_Atl6hEo95-XqkPQr6vz77UapX5Z3u-m9f_TfkLVZW-ew</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1781761227</pqid></control><display><type>article</type><title>Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests</title><source>PubMed Central</source><creator>Berkman, N ; Avital, A ; Breuer, R ; Bardach, E ; Springer, C ; Godfrey, S</creator><creatorcontrib>Berkman, N ; Avital, A ; Breuer, R ; Bardach, E ; Springer, C ; Godfrey, S</creatorcontrib><description>Background: Bronchial provocation tests such as exercise, methacholine (MCH), and adenosine-5′-monophosphate (AMP) challenges are used extensively in the diagnosis of asthma. A study was undertaken to determine whether exhaled nitric oxide (eNO) can be used to diagnose asthma in patients with non-specific respiratory symptoms and to compare this test with conventional provocation tests. Methods: Patients with non-specific respiratory symptoms and normal spirometric parameters were included in the study. eNO was measured and exercise, MCH and AMP challenges performed in all subjects. Patients were defined as asthmatic based on clinical follow up 24 months after testing. Results: Forty patients were considered asthmatic and 45 were not. The area under receiver operating characteristic curves gave values of 0.896 for eNO, 0.781 for exercise, 0.924 for MCH, and 0.939 for AMP (p = 0.033, 0.575 and 0.085 for eNO v exercise, MCH and AMP respectively). From our data, a cut off value of NO &gt;7 ppb at a flow rate of 250 ml/s best differentiates between asthmatics and non-asthmatics (sensitivity 82.5%, specificity 88.9%). Optimal cut off values for other tests were exercise: ΔFEV1 ⩾10% (sensitivity 57.9%, specificity 100%); PC20-MCH: ⩽3 mg/ml (sensitivity 87.5%, specificity 86.7%); and PC20-AMP: ⩽150 mg/ml (sensitivity 89.5%, specificity 95.6%). Conclusions: Measurement of eNO can be used as a safe, simple and rapid test for the diagnosis of asthma and is as good as bronchial provocation tests.</description><identifier>ISSN: 0040-6376</identifier><identifier>EISSN: 1468-3296</identifier><identifier>DOI: 10.1136/thx.2004.031104</identifier><identifier>PMID: 15860713</identifier><identifier>CODEN: THORA7</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and British Thoracic Society</publisher><subject>adenosine 5′-monophosphate ; adenosine 5′-monophosphate (AMP) ; Adenosine Monophosphate - analysis ; Adult ; Airway management ; AMP ; Asthma ; Asthma - diagnosis ; Biological and medical sciences ; Breath Tests ; Bronchial Provocation Tests - methods ; Bronchoconstrictor Agents ; Chronic obstructive pulmonary disease, asthma ; diagnosis ; eNO ; exercise ; Exercise Test ; exhaled nitric oxide ; Female ; FEV1 ; Follow-Up Studies ; Forced Expiratory Volume - physiology ; forced expiratory volume in 1 second ; forced vital capacity ; FVC ; Humans ; Male ; MCH ; Medical sciences ; methacholine ; Methacholine Chloride ; Nitric oxide ; Nitric Oxide - analysis ; Patients ; Pneumology ; Retrospective Studies ; Statistics, Nonparametric ; Steroids ; Vital Capacity - physiology</subject><ispartof>Thorax, 2005-05, Vol.60 (5), p.383-388</ispartof><rights>Copyright 2005 Thorax</rights><rights>2005 INIST-CNRS</rights><rights>Copyright: 2005 Copyright 2005 Thorax</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b522t-78b3b7778a1f31c9de0b1a20f9010c5e64cdd8bb1900ae1fde5c45120fd154e03</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1758892/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1758892/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16846704$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15860713$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Berkman, N</creatorcontrib><creatorcontrib>Avital, A</creatorcontrib><creatorcontrib>Breuer, R</creatorcontrib><creatorcontrib>Bardach, E</creatorcontrib><creatorcontrib>Springer, C</creatorcontrib><creatorcontrib>Godfrey, S</creatorcontrib><title>Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests</title><title>Thorax</title><addtitle>Thorax</addtitle><description>Background: Bronchial provocation tests such as exercise, methacholine (MCH), and adenosine-5′-monophosphate (AMP) challenges are used extensively in the diagnosis of asthma. A study was undertaken to determine whether exhaled nitric oxide (eNO) can be used to diagnose asthma in patients with non-specific respiratory symptoms and to compare this test with conventional provocation tests. Methods: Patients with non-specific respiratory symptoms and normal spirometric parameters were included in the study. eNO was measured and exercise, MCH and AMP challenges performed in all subjects. Patients were defined as asthmatic based on clinical follow up 24 months after testing. Results: Forty patients were considered asthmatic and 45 were not. The area under receiver operating characteristic curves gave values of 0.896 for eNO, 0.781 for exercise, 0.924 for MCH, and 0.939 for AMP (p = 0.033, 0.575 and 0.085 for eNO v exercise, MCH and AMP respectively). From our data, a cut off value of NO &gt;7 ppb at a flow rate of 250 ml/s best differentiates between asthmatics and non-asthmatics (sensitivity 82.5%, specificity 88.9%). Optimal cut off values for other tests were exercise: ΔFEV1 ⩾10% (sensitivity 57.9%, specificity 100%); PC20-MCH: ⩽3 mg/ml (sensitivity 87.5%, specificity 86.7%); and PC20-AMP: ⩽150 mg/ml (sensitivity 89.5%, specificity 95.6%). Conclusions: Measurement of eNO can be used as a safe, simple and rapid test for the diagnosis of asthma and is as good as bronchial provocation tests.</description><subject>adenosine 5′-monophosphate</subject><subject>adenosine 5′-monophosphate (AMP)</subject><subject>Adenosine Monophosphate - analysis</subject><subject>Adult</subject><subject>Airway management</subject><subject>AMP</subject><subject>Asthma</subject><subject>Asthma - diagnosis</subject><subject>Biological and medical sciences</subject><subject>Breath Tests</subject><subject>Bronchial Provocation Tests - methods</subject><subject>Bronchoconstrictor Agents</subject><subject>Chronic obstructive pulmonary disease, asthma</subject><subject>diagnosis</subject><subject>eNO</subject><subject>exercise</subject><subject>Exercise Test</subject><subject>exhaled nitric oxide</subject><subject>Female</subject><subject>FEV1</subject><subject>Follow-Up Studies</subject><subject>Forced Expiratory Volume - physiology</subject><subject>forced expiratory volume in 1 second</subject><subject>forced vital capacity</subject><subject>FVC</subject><subject>Humans</subject><subject>Male</subject><subject>MCH</subject><subject>Medical sciences</subject><subject>methacholine</subject><subject>Methacholine Chloride</subject><subject>Nitric oxide</subject><subject>Nitric Oxide - analysis</subject><subject>Patients</subject><subject>Pneumology</subject><subject>Retrospective Studies</subject><subject>Statistics, Nonparametric</subject><subject>Steroids</subject><subject>Vital Capacity - physiology</subject><issn>0040-6376</issn><issn>1468-3296</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNqFkc2LFDEUxIMo7rh69iYB0YPQs3n9kaQ9CDKsrrD4AepBhPA6nd7O2J2MSWYd_3uzzrCrXjy9Q_1eUUUR8hDYEqDiJ2ncLUvG6iWrAFh9iyyg5rKoypbfJosssIJXgh-RezGuGWMSQNwlR9BIzgRUC_L1dDfiZHrqbApWU7-zvaHW0TQa2lu8cD7aSP1AMaZxxudU-3mDwUbv6A-bRtoF7_RocaKb4C-9xmSzlExM8T65M-AUzYPDPSafXp1-XJ0V5-9ev1m9PC-6pixTIWRXdUIIiTBUoNvesA6wZEPLgOnG8Fr3vew6aBlDA0NvGl03kIEemtqw6pi82Ptutt1sem1cCjipTbAzhp_Ko1V_K86O6sJfKhCNlG2ZDZ4eDIL_vs3R1WyjNtOEzvhtVFyItpQtz-Djf8C13waXy2UvCYJDWYpMnewpHXyMwQzXUYCpq91U3k1d7ab2u-WPR382uOEPQ2XgyQHAqHEaAjpt4w3HZc3Fb6Niz9mYzO5ax_Atl6hEo95-XqkPQr6vz77UapX5Z3u-m9f_TfkLVZW-ew</recordid><startdate>20050501</startdate><enddate>20050501</enddate><creator>Berkman, N</creator><creator>Avital, A</creator><creator>Breuer, R</creator><creator>Bardach, E</creator><creator>Springer, C</creator><creator>Godfrey, S</creator><general>BMJ Publishing Group Ltd and British Thoracic Society</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><general>BMJ Group</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20050501</creationdate><title>Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests</title><author>Berkman, N ; Avital, A ; Breuer, R ; Bardach, E ; Springer, C ; Godfrey, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b522t-78b3b7778a1f31c9de0b1a20f9010c5e64cdd8bb1900ae1fde5c45120fd154e03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>adenosine 5′-monophosphate</topic><topic>adenosine 5′-monophosphate (AMP)</topic><topic>Adenosine Monophosphate - analysis</topic><topic>Adult</topic><topic>Airway management</topic><topic>AMP</topic><topic>Asthma</topic><topic>Asthma - diagnosis</topic><topic>Biological and medical sciences</topic><topic>Breath Tests</topic><topic>Bronchial Provocation Tests - methods</topic><topic>Bronchoconstrictor Agents</topic><topic>Chronic obstructive pulmonary disease, asthma</topic><topic>diagnosis</topic><topic>eNO</topic><topic>exercise</topic><topic>Exercise Test</topic><topic>exhaled nitric oxide</topic><topic>Female</topic><topic>FEV1</topic><topic>Follow-Up Studies</topic><topic>Forced Expiratory Volume - physiology</topic><topic>forced expiratory volume in 1 second</topic><topic>forced vital capacity</topic><topic>FVC</topic><topic>Humans</topic><topic>Male</topic><topic>MCH</topic><topic>Medical sciences</topic><topic>methacholine</topic><topic>Methacholine Chloride</topic><topic>Nitric oxide</topic><topic>Nitric Oxide - analysis</topic><topic>Patients</topic><topic>Pneumology</topic><topic>Retrospective Studies</topic><topic>Statistics, Nonparametric</topic><topic>Steroids</topic><topic>Vital Capacity - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Berkman, N</creatorcontrib><creatorcontrib>Avital, A</creatorcontrib><creatorcontrib>Breuer, R</creatorcontrib><creatorcontrib>Bardach, E</creatorcontrib><creatorcontrib>Springer, C</creatorcontrib><creatorcontrib>Godfrey, S</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Thorax</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Berkman, N</au><au>Avital, A</au><au>Breuer, R</au><au>Bardach, E</au><au>Springer, C</au><au>Godfrey, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests</atitle><jtitle>Thorax</jtitle><addtitle>Thorax</addtitle><date>2005-05-01</date><risdate>2005</risdate><volume>60</volume><issue>5</issue><spage>383</spage><epage>388</epage><pages>383-388</pages><issn>0040-6376</issn><eissn>1468-3296</eissn><coden>THORA7</coden><abstract>Background: Bronchial provocation tests such as exercise, methacholine (MCH), and adenosine-5′-monophosphate (AMP) challenges are used extensively in the diagnosis of asthma. A study was undertaken to determine whether exhaled nitric oxide (eNO) can be used to diagnose asthma in patients with non-specific respiratory symptoms and to compare this test with conventional provocation tests. Methods: Patients with non-specific respiratory symptoms and normal spirometric parameters were included in the study. eNO was measured and exercise, MCH and AMP challenges performed in all subjects. Patients were defined as asthmatic based on clinical follow up 24 months after testing. Results: Forty patients were considered asthmatic and 45 were not. The area under receiver operating characteristic curves gave values of 0.896 for eNO, 0.781 for exercise, 0.924 for MCH, and 0.939 for AMP (p = 0.033, 0.575 and 0.085 for eNO v exercise, MCH and AMP respectively). From our data, a cut off value of NO &gt;7 ppb at a flow rate of 250 ml/s best differentiates between asthmatics and non-asthmatics (sensitivity 82.5%, specificity 88.9%). Optimal cut off values for other tests were exercise: ΔFEV1 ⩾10% (sensitivity 57.9%, specificity 100%); PC20-MCH: ⩽3 mg/ml (sensitivity 87.5%, specificity 86.7%); and PC20-AMP: ⩽150 mg/ml (sensitivity 89.5%, specificity 95.6%). Conclusions: Measurement of eNO can be used as a safe, simple and rapid test for the diagnosis of asthma and is as good as bronchial provocation tests.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and British Thoracic Society</pub><pmid>15860713</pmid><doi>10.1136/thx.2004.031104</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0040-6376
ispartof Thorax, 2005-05, Vol.60 (5), p.383-388
issn 0040-6376
1468-3296
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1758892
source PubMed Central
subjects adenosine 5′-monophosphate
adenosine 5′-monophosphate (AMP)
Adenosine Monophosphate - analysis
Adult
Airway management
AMP
Asthma
Asthma - diagnosis
Biological and medical sciences
Breath Tests
Bronchial Provocation Tests - methods
Bronchoconstrictor Agents
Chronic obstructive pulmonary disease, asthma
diagnosis
eNO
exercise
Exercise Test
exhaled nitric oxide
Female
FEV1
Follow-Up Studies
Forced Expiratory Volume - physiology
forced expiratory volume in 1 second
forced vital capacity
FVC
Humans
Male
MCH
Medical sciences
methacholine
Methacholine Chloride
Nitric oxide
Nitric Oxide - analysis
Patients
Pneumology
Retrospective Studies
Statistics, Nonparametric
Steroids
Vital Capacity - physiology
title Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T03%3A47%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Exhaled%20nitric%20oxide%20in%20the%20diagnosis%20of%20asthma:%20comparison%20with%20bronchial%20provocation%20tests&rft.jtitle=Thorax&rft.au=Berkman,%20N&rft.date=2005-05-01&rft.volume=60&rft.issue=5&rft.spage=383&rft.epage=388&rft.pages=383-388&rft.issn=0040-6376&rft.eissn=1468-3296&rft.coden=THORA7&rft_id=info:doi/10.1136/thx.2004.031104&rft_dat=%3Cproquest_pubme%3E4026836941%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b522t-78b3b7778a1f31c9de0b1a20f9010c5e64cdd8bb1900ae1fde5c45120fd154e03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1781761227&rft_id=info:pmid/15860713&rfr_iscdi=true